**Core Concept**
Mantle cell lymphomas are a type of B-cell non-Hodgkin lymphoma characterized by the overexpression of cyclin D1 due to the t(11;14) translocation. The diagnosis of mantle cell lymphoma relies heavily on immunophenotypic markers that distinguish it from other types of lymphomas.

**Why the Correct Answer is Right**
Mantle cell lymphomas are typically positive for CD5, CD20, and CD43, which are surface antigens that help identify this subtype of lymphoma. The presence of CD5 and CD20 is particularly useful in distinguishing mantle cell lymphoma from other types of B-cell lymphomas. CD43 is also often expressed on the surface of mantle cell lymphoma cells. In contrast, CD23 is typically negative in mantle cell lymphomas and is more commonly associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.

**Why Each Wrong Option is Incorrect**
**Option B:** CD20 is a pan-B-cell marker, and mantle cell lymphomas are B-cell in origin, so it is not surprising that CD20 is positive in these lymphomas.
**Option C:** CD5 is a marker that is often co-expressed with CD20 in mantle cell lymphomas, making it a useful marker for diagnosis.
**Option D:** CD43 is also a common marker in mantle cell lymphomas, and its expression helps to distinguish these lymphomas from other types of B-cell lymphomas.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that mantle cell lymphomas often co-express CD5 and CD20, making these markers useful in the diagnosis of this subtype of lymphoma. In contrast, CD23 is typically negative in mantle cell lymphomas and is more commonly associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.

**✓ Correct Answer: A. CD 23**